China
· Delayed Price · Currency is CNY APT Medical Statistics
Total Valuation
APT Medical has a market cap or net worth of CNY 39.06 billion. The enterprise value is 37.91 billion.
| Market Cap | 39.06B |
| Enterprise Value | 37.91B |
Important Dates
The next estimated earnings date is Friday, August 22, 2025.
| Earnings Date | Aug 22, 2025 |
| Ex-Dividend Date | Jun 19, 2025 |
Share Statistics
APT Medical has 141.01 million shares outstanding. The number of shares has decreased by -0.34% in one year.
| Current Share Class | 141.01M |
| Shares Outstanding | 141.01M |
| Shares Change (YoY) | -0.34% |
| Shares Change (QoQ) | +0.67% |
| Owned by Insiders (%) | 15.14% |
| Owned by Institutions (%) | 26.81% |
| Float | 69.18M |
Valuation Ratios
The trailing PE ratio is 54.57 and the forward PE ratio is 30.00.
| PE Ratio | 54.57 |
| Forward PE | 30.00 |
| PS Ratio | 17.96 |
| PB Ratio | 14.27 |
| P/TBV Ratio | 17.33 |
| P/FCF Ratio | 186.87 |
| P/OCF Ratio | 49.11 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 43.98, with an EV/FCF ratio of 181.37.
| EV / Earnings | 52.94 |
| EV / Sales | 17.43 |
| EV / EBITDA | 43.98 |
| EV / EBIT | 49.23 |
| EV / FCF | 181.37 |
Financial Position
The company has a current ratio of 4.72, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.72 |
| Quick Ratio | 3.49 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.07 |
| Interest Coverage | 313.36 |
Financial Efficiency
Return on equity (ROE) is 28.95% and return on invested capital (ROIC) is 19.77%.
| Return on Equity (ROE) | 28.95% |
| Return on Assets (ROA) | 16.73% |
| Return on Invested Capital (ROIC) | 19.77% |
| Return on Capital Employed (ROCE) | 27.77% |
| Revenue Per Employee | 851,175 |
| Profits Per Employee | 280,297 |
| Employee Count | 2,555 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 1.57 |
Taxes
In the past 12 months, APT Medical has paid 101.66 million in taxes.
| Income Tax | 101.66M |
| Effective Tax Rate | 12.67% |
Stock Price Statistics
The stock price has increased by +34.19% in the last 52 weeks. The beta is -0.35, so APT Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.35 |
| 52-Week Price Change | +34.19% |
| 50-Day Moving Average | 284.58 |
| 200-Day Moving Average | 259.58 |
| Relative Strength Index (RSI) | 63.45 |
| Average Volume (20 Days) | 1,015,825 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, APT Medical had revenue of CNY 2.17 billion and earned 716.16 million in profits. Earnings per share was 5.08.
| Revenue | 2.17B |
| Gross Profit | 1.57B |
| Operating Income | 770.14M |
| Pretax Income | 802.10M |
| Net Income | 716.16M |
| EBITDA | 851.95M |
| EBIT | 770.14M |
| Earnings Per Share (EPS) | 5.08 |
Balance Sheet
The company has 1.20 billion in cash and 13.86 million in debt, giving a net cash position of 1.18 billion or 8.39 per share.
| Cash & Cash Equivalents | 1.20B |
| Total Debt | 13.86M |
| Net Cash | 1.18B |
| Net Cash Per Share | 8.39 |
| Equity (Book Value) | 2.74B |
| Book Value Per Share | 19.19 |
| Working Capital | 1.38B |
Cash Flow
In the last 12 months, operating cash flow was 795.46 million and capital expenditures -586.43 million, giving a free cash flow of 209.04 million.
| Operating Cash Flow | 795.46M |
| Capital Expenditures | -586.43M |
| Free Cash Flow | 209.04M |
| FCF Per Share | 1.48 |
Margins
Gross margin is 72.21%, with operating and profit margins of 35.41% and 32.93%.
| Gross Margin | 72.21% |
| Operating Margin | 35.41% |
| Pretax Margin | 36.88% |
| Profit Margin | 32.93% |
| EBITDA Margin | 39.17% |
| EBIT Margin | 35.41% |
| FCF Margin | 9.61% |
Dividends & Yields
This stock pays an annual dividend of 1.21, which amounts to a dividend yield of 0.44%.
| Dividend Per Share | 1.21 |
| Dividend Yield | 0.44% |
| Dividend Growth (YoY) | 26.88% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 18.69% |
| Buyback Yield | 0.34% |
| Shareholder Yield | 0.75% |
| Earnings Yield | 1.83% |
| FCF Yield | 0.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 26, 2024. It was a forward split with a ratio of 1.45.
| Last Split Date | Jul 26, 2024 |
| Split Type | Forward |
| Split Ratio | 1.45 |
Scores
APT Medical has an Altman Z-Score of 52.44 and a Piotroski F-Score of 7.
| Altman Z-Score | 52.44 |
| Piotroski F-Score | 7 |